Clinical Trial

Effect of Higher Protein Dosing in Critically Ill Patients

Study Description

The Effect of Higher Protein Dosing in Critically Ill Patients

The investigator will investigate the effects of higher protein/amino acid dosing (a?Y2.2 g/kg/d) vs usual protein/amino acid dosing (a?$1.2 g/kg/d) on clinical outcomes in nutritionally high risk ill patients.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Usual Protein/Amino Acid Group

Protein targets will be set using pre-ICU dry actual weight. For patients with BMI >30, ideal body weight based on a BMI of 25 will be used. We will endorse the guidelines for energy targets set forth by ASPEN/SCCM, especially as it pertains to the obese patient.

Higher Protein/Amino Acid Group

Protein targets will be set using pre-ICU dry actual weight. For patients with BMI >30, ideal body weight based on a BMI of 25 will be used. We will endorse the guidelines for energy targets set forth by ASPEN/SCCM, especially as it pertains to the obese patient.

Additional Information

Official Study Title

The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry-based Randomized Trial

Clinical Trial ID

NCT03160547

ParticipAid ID

mepD2e